|
|
Home > Health
Conditions > Senescent Cells
Senescent Cells
Alternative News:
-
Exercise Counters the
Age-related Accumulation of Senescent Cells - Medscape, 1/20/23 -
"Exercise is, arguably, the most effective means to
extend human healthspan. New insights into the mechanisms through which exercise
optimizes function and counters disease have the potential to guide public
health initiatives to promote physical activity and, concurrently, reveal
biology that may be targeted through pharmacological intervention. The
literature summarized herein suggests exercise both counters diverse forms of
molecular damage that cause cellular senescence and potentially promotes
immune-mediated senescent cell clearance. This evidence supports the hypothesis
that exercise prevents the age-associated accumulation of senescent cells.
Although more comprehensive and confirmatory studies are needed, the
senotherapeutic effects of exercise have been demonstrated in multiple tissues
in both preclinical models and humans"
-
Resveratrol induces DNA
damage-mediated cancer cell senescence through the DLC1-DYRK1A-EGFR axis -
Food Funct 2023 Jan 18 - "Inducing cell senescence is
widely regarded as a potent tumor suppression mechanism. Resveratrol has
attracted increasing attention for its capacity to prevent and suppress cancer.
However, the mechanism of resveratrol on the induction of cancer cell senescence
has not been well clarified. Our results showed that resveratrol inhibited cell
viability and colony formation and promoted cell senescence along with
augmentation of SA-β-gal activity and modulation of senescence-associated
molecular markers p53, p21 and LaminB protein in breast and liver cancer cells
... This is the first report to investigate whether resveratrol induces DNA
damage-mediated cancer cell senescence through the DLC1-DYRK1A-EGFR axis, which
could provide a solid base for resveratrol's application in cancer prevention
and clinical treatment as a food additive or adjuvant therapies." - See
resveratrol products at Amazon.com.
-
NMN Shown To Remove Senescent Cells In
Aging Eyes - YouTube, Modern Healthspan - See
NMN at Amazon.com.
-
Combined use of dasatinib
and quercetin alleviates overtraining-induced deficits in learning and memory
through eliminating senescent cells and reducing apoptotic cells in rat
hippocampus - Behav Brain Res 2022 Dec 16 -
"Excessive physical exercise (overtraining, OT) charactered by long-term and
excessive training results in the damage of multiple vital tissues including
hippocampus which plays a critical role in learning and memory. A combination of
dasatinib (D) plus quercetin (Q) (D+Q) belongs to senolytic drugs which
selectively kill senescent cells in vitro and vivo ... These results indicated
that D+Q alleviates overtraining-induced deficits in learning and memory through
elimination of senescent cells and reduction of apoptotic cell number" -
See quercetin at Amazon.com.
-
Downregulation of Sirt6 by
CD38 promotes cell senescence and aging - Aging (Albany NY) 2022 Dec 6 -
"Decreased nicotinamide adenine dinucleotide (NAD+)
levels accompany aging. CD38 is the main cellular NADase. Cyanidin-3-O-glucoside
(C3G), a natural inhibitor of CD38, is a well-known drug that extends the human
lifespan ... We suggest that CD38 downregulates Sirt6 expression to promote cell
senescence and C3G exerts an antiaging effect through CD38-Sirt6 signaling"
- See cyanidin 3-glucoside supplements at
Amazon.com.
-
Showing
Compound Cyanidin 3-glucoside - foodb -
"Outside of the human body, Cyanidin
3-glucoside is found, on average, in the highest
concentration within a few different foods, such as black
elderberries, rubus (blackberry, raspberry), and bilberries
and in a lower concentration in redcurrants, strawberries,
and sweet oranges"
-
Nicotinamide mononucleotide
alleviates osteoblast senescence induction and promotes bone healing in
osteoporotic mice - J Gerontol A Biol Sci Med Sci 2022 Aug 29 -
"Combating the accumulated senescent cells and the
healing of osteoporotic bone fracture in the elderly remains a significant
challenge. Nicotinamide mononucleotide (NMN), a precursor of NAD +, is an
excellent candidate for mitigating aging-related disorders. However, it is
unknown if NMN can alleviate senescent cell induction and enhance osteoporotic
bone fracture healing. Here we show that NMN treatment partially reverses the
effects of tumor necrosis factor-alpha (TNF-α) on human primary osteoblasts
(HOBs): senescent cell induction, diminished osteogenic differentiation ability
and intracellular NAD + and NADH levels. Mechanistically, NMN restores the
mitochondrial dysfunction in HOBs induced by TNF-α evidenced by increased
mitochondrial membrane potential and reduced reactive oxidative species and
mitochondrial mass. NMN also increases mitophagy activity by down-regulating P62
expression and up-regulating light chain 3B-II (LC3B-II) protein expression. In
addition, the cell senescence protective effects of NMN on HOBs are mitigated by
a mitophagy inhibitor (Bafilomycin A1). In vivo, NMN supplementation attenuates
senescent cell induction in growth plates, partially prevents osteoporosis in an
ovariectomized mouse model and accelerates bone healing in osteoporotic mice. We
conclude that NMN can be a novel and promising therapeutic candidate to enhance
bone fracture healing capacity in the elderly." - See
NMN at Amazon.com.
-
Artemisia argyi exhibits
anti-aging effects through decreasing the senescence in aging stem cells -
Aging (Albany NY) 2022 Aug 9 - "Aging is accompanied by
functional loss of many cellular pathways, creating an increased risk of many
age-related complications (ARC). Aging causes stem cell exhaustion with a
concomitant increase in cellular dysfunction. Recently, interest in
senotherapeutics has been growing rapidly to promote healthy aging and as an
intervention for ARCs. This research focused on screening the senomorphic
properties of Artemisia argyi, as an emerging strategy for longevity, and
prevention or treatment of ARCs. In this study, we aimed to find the clinical
efficacy of daily consumption of Artemisia argyi water extract (AAW) on aging
... In vitro study showed the protective effect of AAW in telomere shortening
and helps in maintaining a balance in the expression of anti-aging protein
Klotho and TERT. AAW effectively reduced mitochondrial superoxide and also
provided a protective shield against senescence markers like over-expression of
p21 and formation of double strand breaks, which is known to cause premature
aging. Moreover, animal studies indicated that AAW promoted the expression of
Klotho in naturally aging rats. In addition, AAW successfully restored the
decline cardiac function and improved the grip strength and memory of aging rat.
These findings showed that therapeutic targeting of senescent stem cells by AAW
restored stem cell homeostasis and improves overall health" - See
Artemisia argyi at Amazon.com.
-
Nicotinamide
Mononucleotide Ameliorates Cellular Senescence and Inflammation Caused by Sodium
Iodate in RPE - Oxid Med Cell Longev 2022 Jul 18 -
"retinal pigment epithelium (RPE) ... The protective effects of NMN were demonstrated to rely on undisturbed Sirt1
signaling. Moreover, both the expression of senescence markers of RPE and subretinal inflammatory cell infiltration were decreased by NMN treatment in
vivo. Our results indicate that RPE senescence induced by NaIO3 acquired several
key features of AMD. More importantly, NMN may potentially be used to treat RPE
senescence and senescence-associated pre-AMD changes by restoring the NAD+
levels in cells and tissues." - See
NMN at Amazon.com.
-
Curcumin Alleviates D-Galactose-Induced
Cardiomyocyte Senescence by Promoting Autophagy via the SIRT1/AMPK/mTOR Pathway
- Evid Based Complement Alternat Med 2022 Jul 16 -
"Oxidative stress and impaired autophagy are the hallmarks of cardiac aging.
However, there are no specific drugs available to prevent cardiac aging.
Curcumin is a natural polyphenolic drug with antioxidant, antiaging, and
autophagy-promoting effects. Here, we describe the preventive role of Curcumin
in cardiac aging through the induction of autophagy and the restoration of
autophagy via the SIRT1/AMPK/mTOR pathway. The number of cells positive for
senescence-associated β-galactosidase, P53, P16, and intracellular ROS increased
significantly in senescent cardiomyocytes, stimulated using D-galactose.
Curcumin reversed this effect in a dose-dependent manner. Curcumin-induced
autophagy increased the expression of SIRT1and phosphorylated AMPK and decreased
phosphorylated mTOR in a dose-dependent manner. SIRT1-siRNA-mediated knockdown
inhibited the antioxidation, antiaging, the promotion of autophagy, and the
SIRT1/AMPK/mTOR pathway activation effect of curcumin. Therefore, curcumin could
be an effective anticardiac aging drug" - See
curcumin at Amazon.com.
-
Metformin mitigates
stress-induced premature senescence by upregulating AMPKα at Ser485
phosphorylation induced SIRT3 expression and inactivating mitochondrial oxidants
- Mech Ageing Dev 2022 Jul 18 - "The senescence of
vascular smooth muscle cells (VSMCs) is an important cause of cardiovascular
disease such as atherosclerosis and hypertension. These senescence may be
triggered by many factors, such as oxidative stress, inflammation, DNA damage,
and senescence-associated secretory phenotypes (SASPs). Mitochondrial oxidative
stress induces cellular senescence, but the mechanisms by which mitochondrial
reactive oxygen species (mtROS) regulates cellular senescence are still largely
unknown ... This study provides mechanistic evidence that metformin acts as an
anti-aging agent and alleviates VSMC senescence by upregulating mitochondrial
antioxidant induced p-AMPK (Ser485)-dependent SIRT3 expression, which suggests
metformin has therapeutic potential for the treatment of age-associated vascular
disease" - See
metformin at ReliableRX.
-
New Horizons in the
Treatment of Age-Associated Obesity, Sarcopenia and Osteoporosis - Drugs
Aging 2022 Jul 4 - "The rapid increase in both the
lifespan and proportion of older adults in developed countries is accompanied by
the dramatic growth of age-associated chronic diseases, including obesity,
sarcopenia, and osteoporosis. Hence, prevention and treatment of age-associated
chronic diseases has become increasingly urgent. The key to achieving this goal
is a better understanding of the mechanisms underlying their pathophysiology,
some aspects of which, despite extensive investigation, are still not fully
understood. Aging, obesity, sarcopenia, and osteoporosis are characterized by
the creation of a systemic, chronic, low-grade inflammation (SCLGI). The common
mechanisms that govern the development of these chronic conditions include a
failed resolution of inflammation. Physiologically, the process of inflammation
resolution is provided mainly by specialized pro-resolving mediators (SPMs)
acting via cognate G protein-coupled receptors (GPCRs). Noteworthy, SPM levels
and the expression of their receptors are significantly reduced in aging and the
associated chronic disorders. In preclinical studies, supplementation of SPMs or
their stable, small-molecule SPM mimetics and receptor agonists reveals clear
beneficial effects in inflammation-related obesity and sarcopenic and
osteoporotic conditions, suggesting a translational potential. Age-associated
chronic disorders are also characterized by gut dysbiosis and the accumulation
of senescent cells in the adipose tissue, skeletal muscle, and bones. Based on
these findings, we propose SCLGI resolution as a novel strategy for the
prevention/treatment of age-associated obesity, sarcopenia, and osteoporosis.
Our approach entails the enhancement of inflammation resolution by SPM mimetics
and receptor agonists in concert with probiotics/prebiotics and compounds that
eliminate senescent cells and their pro-inflammatory activity" - See
probiotic supplements at Amazon.com and
prebiotic supplements at
Amazon.com.
-
Doxorubicin-induced
senescence in normal fibroblasts promotes in vitro tumour cell growth and
invasiveness: the role of Quercetin in modulating these processes - Mech
Ageing Dev 2022 Jun 18 - "Ageing is a complex biological
phenomenon representing the major risk factor for developing age-related
diseases, such as cardiovascular pathologies, neurodegenerative diseases, and
cancer. Geroscience, the new vision of gerontology, identifies cellular
senescence as an interconnected biological process that characterises ageing and
age-related diseases. Therefore, many strategies have been employed in the last
years to reduce the harmful effects of senescence, and among these, the most
intriguing ones use nutraceutical compounds. Here we show that a pre-treatment
with Quercetin, a bioactive flavonoid present in many fruits and vegetables,
increasing cellular antioxidant defence, can alleviate Doxorubicin (Doxo)-induced
cellular senescence in human normal WI-38 fibroblasts. Furthermore, our work
demonstrates that Quercetin pre-treatment, reducing the number of senescent
cells and the production of the senescence-associated secretory phenotype (SASP)
factors, can decrease the pro-tumour effects of conditioned medium from Doxo-induced
senescent fibroblasts on osteosarcoma cells. Overall, our findings are
consistent with the hypothesis that targeting senescent cells can be an emerging
strategy for cancer treatment, especially in elderly patients, in which
senescent cells are already abundant in several tissues and organs" - See
quercetin at Amazon.com.
-
Resveratrol drives cancer
cell senescence via enhancing p38MAPK and DLC1 expressions - Food Funct 2022
Mar 2 - "Pro-senescence therapy is a recently proposed
anti-cancer strategy and has been shown to effectively inhibit cancer.
Resveratrol is gaining attention for its cancer preventive and suppressive
properties ... resveratrol induced cell senescence along with an increase of
SA-β-Gal activity and inhibition of colony formation in breast and lung cancer
cells. The underlying mechanisms were that resveratrol induced ER-stress by
increasing SIRT1 to promote p38MAPK expression and by reducing NO level to
up-regulate DLC1 expression, and ER-stress further resulted in DNA damage and
mitochondrial dysfunction, eventually leading to cancer cell senescence. Our
findings on resveratrol's induction of cancer cell senescence via activating
ER-stress through the SIRT1/p38MAPK and NO/DLC1 pathways provide a solid base
for its clinical application and its preventive application as a food additive"
- See resveratrol products at Amazon.com.
-
Enhanced
co-culture and enrichment of human natural killer cells for the
selective clearance of senescent cells - Aging (Albany NY)
2022 Mar 4 - "In the context of aging
and age-associated diseases, Natural Killer (NK) cells have been
revealed as a key cell type responsible for the immune clearance
of senescent cells. Subsequently, NK cell-based therapies have
emerged as promising alternatives to drug-based therapeutic
interventions for the prevention and treatment of age-related
disease and debility. Given the promise of NK cell-mediated
immunotherapies as a safe and effective treatment strategy, we
outline an improved method by which primary NK cells can be
efficiently enriched from human peripheral blood across multiple
donors (ages 20-42 years old), with a practical protocol that
reliably enhances both CD56dim and CD56bright NK cells by
15-fold and 3-fold, respectively. Importantly, we show that our
co-culture protocol can be used as an easily adaptable tool to
assess highly efficient and selective killing of senescent cells
by primary NK cells enriched via our method using longer
co-culture durations and a low target to effector ratio, which
may be more physiological than has been achieved in previous
literature"
-
Whole-body
senescent cell clearance alleviates age-related brain
inflammation and cognitive impairment in mice - Aging Cell
2021 Feb - "Cellular senescence is
characterized by an irreversible cell cycle arrest and a
pro-inflammatory senescence-associated secretory phenotype
(SASP), which is a major contributor to aging and age-related
diseases. Clearance of senescent cells has been shown to improve
brain function in mouse models of neurodegenerative diseases.
However, it is still unknown whether senescent cell clearance
alleviates cognitive dysfunction during the aging process. To
investigate this, we first conducted single-nuclei and
single-cell RNA-seq in the hippocampus from young and aged mice.
We observed an age-dependent increase in p16Ink4a senescent
cells, which was more pronounced in microglia and
oligodendrocyte progenitor cells and characterized by a SASP. We
then aged INK-ATTAC mice, in which p16Ink4a -positive senescent
cells can be genetically eliminated upon treatment with the drug
AP20187 and treated them either with AP20187 or with the
senolytic cocktail Dasatinib and Quercetin. We observed that
both strategies resulted in a decrease in p16Ink4a exclusively
in the microglial population, resulting in reduced microglial
activation and reduced expression of SASP factors. Importantly,
both approaches significantly improved cognitive function in
aged mice. Our data provide proof-of-concept for senolytic
interventions' being a potential therapeutic avenue for
alleviating age-associated cognitive impairment" - See
quercetin at Amazon.com.
-
Dasatinib - Medline Plus -
"Dasatinib is used to treat a
certain type of chronic myeloid leukemia (CML; a type of cancer
of the white blood cells) as a first treatment and in people who
can no longer benefit from other leukemia medications including
imatinib (Gleevec) or in those who cannot take these medications
because of side effects"
-
Fisetin Longevity Benefits | Mayo Clinic
Trials - Dr Brad Stanfield, YouTube
-
What Are Senescent
Cells - Dr James Kirkland Interview Series Ep 2, YouTube
-
Senescent Cells Effect & Benefits of Removing - Dr James
Kirkland Interview Series Ep 3, YouTube
- Cellular
senescence - Wiki - "Cellular senescence is a phenomenon characterized
by the cessation of cell division. In their experiments during the early
1960s, Leonard Hayflick and Paul Moorhead found that normal human fetal
fibroblasts in culture reach a maximum of approximately 50 cell population
doublings before becoming senescent.[1][2][3] This process is known as "replicative
senescence", or the Hayflick limit. Hayflick's discovery of mortal cells
paved the path for the discovery and understanding of cellular aging
molecular pathways.[4] Cellular senescence can be initiated by a wide
variety of stress inducing factors. These stress factors include both
environmental and internal damaging events, abnormal cellular growth,
oxidative stress, autophagy factors, among many other things ... The
physiological importance for cell senescence has been attributed to
prevention of carcinogenesis, and more recently, aging, development, and
tissue repair.[6] Senescent cells contribute to the aging phenotype,
including frailty syndrome, sarcopenia, and aging-associated diseases.[7]
Senescent astrocytes and microglia contribute to neurodegeneration."
- Overview of Cell Senescence -
SENS Foundation, YouTube
-
Fisetin Longevity Benefits | Mayo Clinic
Trials - Dr Brad Stanfield, YouTube
-
Fisetin, Quercetin &
Dasatinib in Clinical Trials - Dr. James Kirkland
Interview Series Ep 4, YouTube - Note: The consensus seems
to be that you should take supplements that eliminate
senescent cells in a hit and run fashion, i.e., take them in
large quantities then stop them for a period of time. This
doctor says the half-life of quercetin is 11 hours and it’s
totally illuminated in three half-life’s or 36 hours.
Fisetin’s half-life is three hours so it’s eliminated in 9
hours. As far as dasatinib, it’s a chemo medication for
leukemia so I doubt if you’ll find a doctor to prescribe it.
Overseas pharmacies sell it for $8.50 per pill. Most
chemotherapy drugs increase senescent cells but dasatinib
works on a different pathway.
-
Combination of dasatinib and quercetin improves cognitive
abilities in aged male Wistar rats, alleviates inflammation
and changes hippocampal synaptic plasticity and histone H3
methylation profile
-
What Are Senescent
Cells - Dr James Kirkland Interview Series Ep 2, YouTube
-
Senescent Cells Effect & Benefits of Removing - Dr James
Kirkland Interview Series Ep 3, YouTube
-
The Role of
Senescence in Driving the Pathology of Aging-Related
Diseases - Nicolas Musi, MD, YouTube
-
Reversal of cell
senescence by resveralogues- from mechanisms to therapies?
- Richard Faragher, YouTube - He claims resveratrol will
reverse senescence (around 20 minutes into the video).
Other News:
-
Cellular senescence and
cardiovascular diseases: moving to the "heart" of the problem -
Physiol Rev 2022 Sep 1 - "Cardiovascular diseases
(CVDs) constitute the prime cause of global mortality with an immense impact
on patient quality of life and disability. Clinical evidence has revealed a
strong connection between cellular senescence and worse cardiac outcomes in
the majority of CVDs concerning both ischemic and non-ischemic
cardiomyopathies. Cellular senescence is characterized by cell cycle arrest
accompanied by alterations in several metabolic pathways, resulting in
morphological and functional changes. Metabolic rewiring of senescent cells
results in marked paracrine activity, through a unique secretome, often
exerting deleterious effects on neighboring cells. Here, we recapitulate the
hallmarks and key molecular pathways involved in cellular senescence in the
cardiac context and summarize the different roles of senescence in the
majority of CVDs. In the last few years, the possibility of eliminating
senescent cells in various pathological conditions is being increasingly
explored, giving rise to the field of senotherapeutics"
-
Transformed cells after
senescence give rise to more severe tumor phenotypes than transformed
non-senescent cells - Cancer Lett 2022 Aug 1 - "Oncogenic
stress-induced senescence initially inhibits tumor initiation by blocking
proliferation and by attracting immune cells to clear potentially harmful
cells. If these cells are not eliminated they may resume proliferation upon
loss-of-tumor suppressors, and be at risk of transformation. During tumor
formation, depending on the sequence of events of gain-of-oncogenes and/or
loss-of-tumor suppressors, cancer cells may emerge from senescent cells.
Here, we show that these transformed cells after senescence (TS) display
more aggressive tumorigenic features, with a greater capacity to migrate and
a higher resistance to anti-tumoral drugs than cells having undergone
transformation without senescence. Bulk transcriptomic analysis and single
cell RNA sequencing revealed a signature unique to TS cells. A score of this
signature was then generated and a high score was correlated with decreased
survival of patients with lung adenocarcinoma, head-neck squamous cell
carcinoma, adrenocortical carcinoma, liver hepatocellular carcinoma, skin
cutaneous melanoma and low-grade glioma. Together, these findings strongly
support that cancer cells arising from senescent cells are more dangerous,
and that a molecular signature of these cells may be of prognostic value for
some human cancers"
-
Cellular senescence: a
key therapeutic target in aging and diseases - J Clin Invest 2022 Aug 1
- "Cellular senescence is a hallmark of aging
defined by stable exit from the cell cycle in response to cellular damage
and stress. Senescent cells (SnCs) can develop a characteristic pathogenic
senescence-associated secretory phenotype (SASP) that drives secondary
senescence and disrupts tissue homeostasis, resulting in loss of tissue
repair and regeneration. The use of transgenic mouse models in which SnCs
can be genetically ablated has established a key role for SnCs in driving
aging and age-related disease. Importantly, senotherapeutics have been
developed to pharmacologically eliminate SnCs, termed senolytics, or
suppress the SASP and other markers of senescence, termed senomorphics.
Based on extensive preclinical studies as well as small clinical trials
demonstrating the benefits of senotherapeutics, multiple clinical trials are
under way"
|
|